ESLA
Estrella Immunopharma, Inc.
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has determined that there is a substantial doubt about its ability to continue as a going concern.”View the 10-Q filed May 18, 2026
Company with tickers: ESLA, ESLAW
CIK
1844417
CUSIP
297584104
Shares Outstanding
43,034,228
Website
https://www.estrellabio.com
Investor Relations
https://www.estrellabio.com/investors
13F Activity (30d)
1 filings
1 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.